CYRX
Cryoport, Inc.
CYRX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
CYRX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Weak |
CYRX's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
CYRX PE Valuation
CYRX has no meaningful PE right now: it lost money over the past year.
CYRX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CYRX's losses to shrink, with revenue growing.
CYRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.89 | -176% |
| Q2 2026 | -$0.82 | -162% |
| Q1 2026 | $1.43 | +$3.77 |
| Q4 2025 | $1.40 | +$3.89 |
| Q3 2025 | $1.17 | +$4.56 |
| Q2 2025 | $1.33 | +$5.01 |
| Q1 2025 | -$2.34 | +$0.14 |
| Q4 2024 | -$2.49 | -$0.28 |
CYRX has swung to a loss: it lost $0.89 per share over the past year, after a profit the year before.
CYRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2M | +14% |
| Q2 2026 | $49M | +7.7% |
| Q1 2026 | $47.8M | +16% |
| Q4 2025 | $45.5M | -24% |
| Q3 2025 | $44.2M | -22% |
| Q2 2025 | $45.5M | -21% |
| Q1 2025 | $41M | -25% |
| Q4 2024 | $59.5M | +4% |
CYRX's revenue is recovering but still below its 2022 peak: $50M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -18% | +4.9 points |
| Q2 2026 | -21% | +0.7 points |
| Q1 2026 | -20% | +3 points |
| Q4 2025 | -22% | +1.3 points |
| Q3 2025 | -22% | +6.5 points |
| Q2 2025 | -21% | +116 points |
| Q1 2025 | -23% | +16 points |
| Q4 2024 | -23% | +99 points |
CYRX's operating margin was −18% last quarter, up 4.9 points from the same quarter a year ago.
CYRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$40K | +$1.2M |
| Q2 2026 | -$8M | +$3.7M |
| Q1 2026 | -$6.2M | +$1.3M |
| Q4 2025 | -$4.5M | +$6.2M |
| Q3 2025 | -$1.3M | +$2.5M |
| Q2 2025 | -$11.7M | +$119K |
| Q1 2025 | -$7.5M | -$239K |
| Q4 2024 | -$10.7M | -$1.6M |
CYRX has burned cash in almost every quarter: −$19M over the past year, against −$31M the year before.
CYRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +211K shares |
| 1 year | +1.1% | +529K shares |
| 3 years | +3.6% | +1.7M shares |
| 5 years | +9.8% | +4.5M shares |
| Available history | +52% | +17.3M shares |
CYRX has 51M diluted shares, up 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $2M |
| Q3 2025 | $3.7M |
| Q4 2022 | $4.6M |
| Q3 2022 | — |
| Q2 2022 | $25M |
| Q1 2022 | $8.3M |
CYRX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | 110.0x | High |
| Q3 2021 | 24.2x | High |
CYRX's net debt is more than 20 years of its operating earnings (EBITDA).
CYRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.7 | Overbought |
| Stochastic | 78.1 | Neutral |
CYRX's weekly RSI is 72 (overbought) and its Stochastic is 78 (neutral).
CYRX PE vs Industrials Sector
| Metric | CYRX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CYRX has no meaningful PE right now: it lost money over the past year.
CYRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.9 | 12% above |
| 20 week MA | $16.7 | 20% above |
| 50 week MA | $13.1 | 53% above |
| 100 week MA | $10.4 | 94% above |
| 200 week MA | $12.4 | 63% above |
CYRX has climbed back above all five of its weekly moving averages, and it's now 63% above its 200-week average.
CYRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.2 | $45.8 | +182% |
| 2021 | $45.8 | $59.5 | +30% |
| 2022 | $59.5 | $16.4 | -72% |
| 2023 | $16.4 | $15.5 | -5.5% |
| 2024 | $15.5 | $7.80 | -50% |
| 2025 | $7.80 | $9.66 | +24% |
| 2026 YTD | $9.66 | $20.1 | +108% |
CYRX's yearly returns have swung widely, from +182% in 2020 to −72% in 2022. It's up 108% so far in 2026.